DNA vaccination is a simple and effective method to induce immune responses against a
variety of tumors as well as infectious diseases. Vaccination with major histocompatibility …

In this study, we explored the protective anti-tumor potency of mouse (self) Hsp70 or Hsp110-
based DNA vaccination approach targeting a tumor-associated antigen, human papilloma …

Delivery of antigens to antigen presenting cells (APCs) is a key issue for developing
effective cancer vaccines. Controlling the tissue distribution of antigens can increase antigen …

Heat shock protein 70 (Hsp70)-associated antigens in a soluble form have been shown to
elicit strong antigen-specific cytotoxic T lymphocyte (CTL) responses following immunization …

Gene-modified cell vaccines are the best way to achieve the immunotherapy for all types of
acute leukemia. In this study, the recombinant eukaryotic expression vector (pDisplay …

DNA vaccines are an appealing strategy for inducing cytotoxic T-lymphocyte and antibody
responses against tumor cells as well as infectious agents. Dendritic cells (DCs) play a …

Studies have demonstrated that active-specific immunotherapy has potential for controlling
mammary tumor progression. Human chorionic gonadotropin (hCG) is expressed and …

Antigen delivery to antigen-presenting cells (APCs) is a key issue in developing effective
cancer vaccines. Controlling the tissue distribution of antigens, which are administered in a …

Heat shock proteins (HSPs) have been recognized as significant participants in immune
reactions. We have previously reported that heat-treated cells expressing HSP70 can …

Heat shock proteins (hsp's) isolated from murine cancer cells can elicit protective immunity
and specific cytotoxic T lymphocytes (CTLs) by channeling tumor-derived peptides bound to …